The Company is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as insulin substitutes, insulin sensitizers, and liver cancer drugs. In addition, the Company also produces lung cancer diagnostic kits. The Company was established on April 1, 2011. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on September 16, 2020.
Headquarters
3-301, (Sampyeong-Dong Pangyo Seven Venture Valley1), 15, Pangyo-Ro 228Beon-Gil, Bundang-Gu
Seongnam; Gyeonggi;
Contact Details: Purchase the Aptamer Sciences Inc. report to view the information.
Website: http://www.aptsci.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service